within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX35_Anagrelide;
model Anagrelide 
   extends Pharmacolibrary.Drugs.ATC.L.L01XX35;

  annotation(Documentation(
    info ="<html><body><p>Anagrelide is a phosphodiesterase 3 (PDE3) inhibitor used for the treatment of essential thrombocythemia (ET) to reduce elevated platelet counts and the risk of thrombosis. It is approved and utilized clinically for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adults and patients with essential thrombocythemia after oral administration.</p><h4>References</h4><ol><li><p>Petrides, PE, et al., &amp; Klade, CS (2018). Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product. <i>Clinical pharmacology in drug development</i> 7(2) 123–131. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.340&quot;>10.1002/cpdd.340</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28301098/&quot;>https://pubmed.ncbi.nlm.nih.gov/28301098</a></p></li><li><p>Pescatore, SL, &amp; Lindley, C (2000). Anagrelide: a novel agent for the treatment of myeloproliferative disorders. <i>Expert opinion on pharmacotherapy</i> 1(3) 537–546. DOI:<a href=&quot;https://doi.org/10.1517/14656566.1.3.537&quot;>10.1517/14656566.1.3.537</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11249536/&quot;>https://pubmed.ncbi.nlm.nih.gov/11249536</a></p></li><li><p>Toivanen, K, et al., &amp; Sihto, H (2025). Pharmacokinetic profile and . <i>Drug delivery</i> 32(1) 2463433–None. DOI:<a href=&quot;https://doi.org/10.1080/10717544.2025.2463433&quot;>10.1080/10717544.2025.2463433</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39930717/&quot;>https://pubmed.ncbi.nlm.nih.gov/39930717</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Anagrelide;
